Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: Receptor binding affinity and specificity

Coronary Artery Disease

Volumn 7, Issue 10, 1996, Pages 767-774

  Mousa, Shaker A ^a   Forsythe, Mark ^a   Lorelli, William ^a   Bozarth, Jeffrey ^a   Xue, Chu Biao ^a   Wityak, John ^a   Sielecki, Thais M ^a   Olson, Rick E ^a   DeGrado, William ^a   Kapil, Ram ^a   Hussain, Munir ^a   Wexler, Ruth ^a   Thoolen, Martin J ^a   Reilly, Thomas M ^a  

^a DUPONT COMPANY   (United States)

Author keywords

antiplatelet; DMP754; GpIIb IIIa receptor; integrins; platelet

Indexed keywords

FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; PRODRUG; ROXIFIBAN; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; BINDING AFFINITY; CELL ADHESION; DRUG EFFICACY; DRUG SPECIFICITY; HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

EID: 8044235823     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199610000-00010     Document Type: Article

References (27)

1. Hirsh PD, Hillis LD, Campbell WB, Firth BF, Willerson JT: Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981, 304:685-691.
2. Rubenstein MD, Wall RT, Bain DS, Harrison DC: Platelet activation in clinical coronary artery disease and spasm. Am Heart J 1981, 102:363-367.
3. Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP: Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 1981, 48:395-402.
4. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA: Platelet activation in unstable coronary disease. N Engl J Med 1986, 315:983-989.
5. Fuster V, Steele PM, Chesebro JH: Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 1985, 5:175B-184B.
6. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM: Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 1989, 80:198-205.
7. Davies MJ, Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and cresendo angina. Br Heart J 1985, 53:363-373.
8. Hamm CW, Bliefield W, Kupper W, Lorenz RL, Weber PC, Wober W: Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 1987, 10:998-1004.
9. Ashby B, Daniel JL, Smith JB: Mechanisms of platelet activation and inhibition. Platelet Health Dis 1990, 4:1-26.
10. Kruithof EKO, Tran-Thang C, Bachman F: Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemost 1986, 55:201-205.
11. Pytela R, Pierschbacher MS, Ginsberg MH, Plow EF, Ruoslahti E: Platelet membrane glycoprotein IIb/IIIa: member of a family of RGD specific adhesion receptors. Science 1986, 231:1559-1562.
12. Philips DR, Charo IF, Scarborough RM: GPIIb/IIIa: the responsive integrin. Cell 1991, 65:359-362.
13. D'Souza SE, Ginsberg MH, Burke TA, Plow EF: The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its a subunit. J Biol Chem 1990, 265:3440-3446.
14. Cook NS, Kottirsch G, Zerwes H-G: Platelet glycoprotein IIb/IIIa antagonists. Drugs of the Future 1994, 19:135-159.
15. Nichols AJ, Ruffolo RR, Huffman WF, Poste G, Samamen J: Development of GPIIb/IIIa antagonists as antithrombotic drugs. Trends Pharmacol Sci 1992, 13:413-417.
16. Coller BS, Folts JD, Scudder LE, Smith SR: Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 1986, 68:783-786.
17. Yasuda T, Gold HK, Yaoita H, Leinbach RC, Guerrero JL, Jang IK, et al.: Comparison effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol 1990, 16:714-722.
18. Topol EJ, PLow EF: Clinical trials of platelet receptor inhibitors. Thromb Haemost 1993, 70:94-98.
19. Peerlinck K, De Lepeleire I, Goldberg M, Farrell D, Barrett J, Hand E, et al.: MK383 (L-700462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation 1993, 88:1512-1517.
20. Topol EJ: Novel antithrombotic approaches to coronary artery diseases. Am J Cardiol 1995, 75:27b-33b.
21. Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, et al.: Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker, Integrelin in elective coronary intervention. IMPACT Investigators. Circulation 1995, 91:215-217.
22. Kottke-Marchant K, Simpfendorfer C, Lowrie M, Burns D, Anders RJ: Sustained but variable inhibition of platelet aggregation with Xemlofiban, an oral GPIIb/IIIa receptor antagonist, in patients with unstable angina. Circulation 1995, 92 (suppl 8):1488.
23. Narjes H, Weisenberger H, Muller TH, Deichsel G, Krause J: Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with BIBU 104 xx in healthy volunteers [abstract]. Thromb Haemost 1995, 73:1315.
24. Mousa S, Bozarth J, Forsythe M, Jackson S, Leamy A, Diemer M, et al.: Antiplatelet, antithrombotic efficacy of DMP728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation 1994, 89:3-12.
25. Mousa S, Bozarth J, Forsythe M, Lorelli W, Jackson S, Ramachandran N, et al.: Antiplatelet efficacy and specificity of a novel platelet GPIIb/IIIa receptor antagonist, DMP728. Cardiology 1993, 83:374-382.
26. Bennett JS, Vilaire GO: Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979, 64:1393-1401.
27. Mousa S, Mayo MC, Bozarth JM, Forsythe MS, Reilly TM: Antiplatelet effects of thrombin inhibitors versus GPIIb/IIIa receptor antagonists: comparative kinetic and mechanistic analysis [abstract]. Thromb Haemost 1993, 69:2792.